[Inhibitors of alpha-glucosidase].
Toeller
M
M
Diabetes Research Institute, Heinrich Heine University, Düsseldorf, Allemagne.
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D020909:Acarbose; D001786:Blood Glucose / Q000187:drug effects; D050260:Carbohydrate Metabolism; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D004063:Digestion / Q000187:drug effects; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D065089:Glycoside Hydrolase Inhibitors; D050112:Imino Pyranoses; D007328:Insulin / Q000097:blood; D014280:Triglycerides / Q000097:blood; D014312:Trisaccharides / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D001786:Blood Glucose; D065089:Glycoside Hydrolase Inhibitors; D050112:Imino Pyranoses; D007328:Insulin; D014280:Triglycerides; D014312:Trisaccharides; C045621:miglitol; D017485:1-Deoxynojirimycin; D005944:Glucosamine; D020909:Acarbose
Inhibiteurs de l'alpha-glucosidase.